DBV Technologies

DBV Technologies Dividend Coverage

Dividend Coverage Ratio of DBV Technologies (DBVT) as of Oct 17, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of DBV Technologies is 2026 - . Dividend Coverage Ratio of DBV Technologies was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DBV Technologies Stock analysis

What does DBV Technologies do? DBV Technologies, headquartered in Châtillon, France, is a clinical-stage biopharmaceutical company focused on developing epicutaneous immunotherapy products for food allergies. The company's pipeline includes Viaskin Peanut, which completed Phase 3 trials for peanut allergy treatment, and Viaskin Milk, in Phase 1/2 for cow's milk protein allergy. It also develops the Viaskin technology platform and collaborates with Nestlé Health Science on MAG1C for diagnosing non-IgE mediated CMPA. Listed in 2014, the company employs 125 people and operates in the Health Care sector. DBV Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DBV Technologies stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio DBV Technologies since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's DBV Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — DBV Technologies

All Key Metrics — DBV Technologies